Cargando…

Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma

BACKGROUND: Multiple myeloma (MM) is a clonal plasma cell disorder which still lacks sufficient prognostic factors. The serine/arginine-rich splicing factor (SRSF) family serves as an important splicing regulator in organ development. Among all members, SRSF1 plays an important role in cell prolifer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiawei, Wang, Zanzan, Wang, Kailai, Xin, Dijia, Wang, Luyao, Fan, Yili, Xu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191755/ https://www.ncbi.nlm.nih.gov/pubmed/37206090 http://dx.doi.org/10.1155/2023/9998927

Ejemplares similares

Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
por: Zhang, Jiawei, et al.
Publicado: (2022)

Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma
por: Xiang, Jing, et al.
Publicado: (2022)

High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma
por: Che, Feifei, et al.
Publicado: (2019)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

PB2080: LOW DUP1 EXPRESSION PREDICTS POOR PROGNOSIS IN MULTIPLE MYELOMA
por: Lu, Jinfeng, et al.
Publicado: (2023)

High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
por: Zhang, Guoshun, et al.
Publicado: (2022)

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
por: Noll, Jacqueline E., et al.
Publicado: (2015)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021)

Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma
por: Zheng, Hongyan, et al.
Publicado: (2022)

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
por: Barwick, Benjamin G., et al.
Publicado: (2019)

Case Report: Radiation necrosis mimicking tumor progression in a patient with extranodal natural killer/T-cell lymphoma
por: Chen, Boxiao, et al.
Publicado: (2023)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
por: Di Lullo, Giulia, et al.
Publicado: (2015)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
por: Liu, Hui, et al.
Publicado: (2020)

TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
por: Lu, Shengkui, et al.
Publicado: (2012)

High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma
por: Fan, Liping, et al.
Publicado: (2017)

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
por: Walker, Brian A, et al.
Publicado: (2015)

Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer
por: Xu, Xin, et al.
Publicado: (2022)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma
por: Fu, Lin, et al.
Publicado: (2020)

Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021)

Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
por: Gautrey, Hannah L., et al.
Publicado: (2012)

Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma
por: Liu, Xianhui, et al.
Publicado: (2020)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis
por: Chen, Xin, et al.
Publicado: (2018)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
por: Zheng, Dong, et al.
Publicado: (2022)

Splicing factor SRSF6 mediates pleural fibrosis
por: Liang, Li-Mei, et al.
Publicado: (2021)

Increased Monocytic Myeloid-Derived Suppressor Cells in Whole Blood Predict Poor Prognosis in Patients with Plasma Cell Myeloma
por: Bae, Mi-Hyun, et al.
Publicado: (2021)

Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1
por: Wang, Xin, et al.
Publicado: (2011)

Corrigendum: Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2022)

Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Limei, et al.
Publicado: (2023)

Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
por: Guo, Mengjie, et al.
Publicado: (2018)

Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma
por: Chen, Hanbin, et al.
Publicado: (2017)

Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma
por: Kim, Miyoung, et al.
Publicado: (2016)

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
por: Pawlyn, C, et al.
Publicado: (2017)

The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma
por: Szudy-Szczyrek, Aneta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f08mso9o63a5unle9mj8jtjfdh